We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
Observe Medical ASA, October 16, 2020: Observe Medical ASA (the "Company" or "Observe Medical") has signed a non-binding term sheet including an exclusive right to acquire 100% of the shares in Sylak AB (“Sylak”), a Swedish private limited company, for an agreed enterprise value of SEK 6 million (on a cash and debt free basis)…
Read moreOslo, 4 September 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 31 August 2020 regarding the exercise of employee share options and issue of 171,875 new shares in the Company. The NOK 44,687.50 share capital increase pertaining to the exercise of the employee share options has now…
Read moreOslo, 31 August 2020: The board of directors of Observe Medical ASA (the "Company") has resolved to increase the share capital of the Company following the completion of an exercise period for vested share options. 1. Exercise of employee share options In total 171,875 employee share options were exercised, giving the option holders the right…
Read moreQuarterly Presentation - Q3
Quarterly Presentation – Q4
Annual Report
Quarterly Presentation - Q1
Annual General Meeting
Half-yearly Report
Quarterly Presentation - Q3
Last updated 8 October 2020
| Name | Number of shares | % of top 20 | % of total | Country | |
|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 4,222,727 | 25.86% | 21.54% | Norway |
| 2 | INGERØ REITEN INV. COMPANY AS | 3,939,394 | 24.13% | 20.09% | Norway |
| 3 | RO, LARS | 1,450,000 | 8.88% | 7.40% | NORWAY |
| 4 | UBS SWITZERLAND AG | 1,420,522 | 8.70% | 7.25% | SWITZERLAND |
| 5 | ARTAL AS | 897,407 | 5.50% | 4.58% | Norway |
| 6 | ALPINE CAPITAL AS | 640,033 | 3.92% | 3.26% | Norway |
| 7 | Soleglad Invest AS | 586,668 | 3.59% | 2.99% | NORWAY |
| 8 | NORDA ASA | 516,570 | 3.16% | 2.63% | Norway |
| 9 | TRANBERGKOLLEN INVEST AS | 500,000 | 3.06% | 2.55% | Norway |
| 10 | LEIKERANE AS | 466,666 | 2.86% | 2.38% | Norway |
| 11 | LAPAS AS | 336,924 | 2.06% | 1.72% | Norway |
| 12 | MP PENSJON PK | 262,025 | 1.60% | 1.34% | NORWAY |
| 13 | KRAEBER VERWALTUNG GMBH | 214,850 | 1.32% | 1.10% | GERMANY |
| 14 | BUKKEVIK INVESTERING AS | 140,160 | 0.86% | 0.71% | norway |
| 15 | BJØRNTVEDT, VEGARD | 136,358 | 0.84% | 0.70% | norway |
| 16 | GINNY INVEST AS | 128,984 | 0.79% | 0.66% | Norway |
| 17 | BJØRNTVEDT, EIVIND | 127,000 | 0.78% | 0.65% | norway |
| 18 | ABC INVEST AS | 120,000 | 0.73% | 0.61% | Norway |
| 19 | NORDNET BANK AB | 116,516 | 0.71% | 0.59% | Sweden |
| 20 | EILERAAS, KARL ANSKAR | 104,490 | 0.64% | 0.53% | nORWAY |
| Total numBer owned by top 20 | 16,327,294 | 100.00% | 83.28% | ||
| Total number of shares | 19,605,457 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Oslo Axess
OBSERV
4 November 2019
Healthcare
NOK
NO0010865009
19 605 457
NOK 0.26
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bernt Olav Røttingsnes (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com